Long-term outcomes of endoscopic balloon dilation for benign strictures in patients with inflammatory bowel disease

Korean Association for the Study of the Intestinal Diseases (KASID)

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background/Aims: Benign intestinal strictures are common complications in patients with inflammatory bowel disease (IBD). This study aimed to assess the long-term prognosis of endoscopic balloon dilation (EBD) to treat benign strictures in IBD patients. Methods: Patients with IBD who had benign strictures and who underwent EBD in four tertiary referral university hospitals between January 2004 and February 2014 were retrospectively reviewed. Technical success was defined as the ability to pass the scope through the stricture after balloon dilation, and clinical success was defined as improved obstructive symptoms. Results: Forty-two benign strictures were identified in 30 patients (15 males and 15 females). Technical success was achieved in 26 patients (86.7%) at the first EBD attempt and in all 30 patients (100%) at the second EBD attempt. Clinical success was seen in 28 patients (93.3%). The median follow-up duration was 134.8 months (range, 10.2 to 252.0 months), and recurrence occurred in eight patients (26.7%), who required repeat EBD. The median duration to relapse was 1.7 months (range, 0.2 to 6.3 months). During repeat EBD, perforation occurred in two cases (6.7%), which were both clipped successfully. Finally, only one patient (3.3%) underwent surgery for the relief of recurrent obstructive symptoms during the follow-up period. Conclusions: The experience of 10 years shows that EBD is safe and effective for the treatment of benign strictures in IBD patients. Importantly, EBD may allow long-term effective palliation of the symptoms associated with benign intestinal strictures in IBD patients.

Original languageEnglish
Pages (from-to)530-536
Number of pages7
JournalGut and liver
Volume12
Issue number5
DOIs
Publication statusPublished - 2018 Sep

Fingerprint

Inflammatory Bowel Diseases
Dilatation
Pathologic Constriction
Recurrence
Tertiary Care Centers

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Korean Association for the Study of the Intestinal Diseases (KASID). / Long-term outcomes of endoscopic balloon dilation for benign strictures in patients with inflammatory bowel disease. In: Gut and liver. 2018 ; Vol. 12, No. 5. pp. 530-536.
@article{075dddbedf2941739d166c85d62ecbf4,
title = "Long-term outcomes of endoscopic balloon dilation for benign strictures in patients with inflammatory bowel disease",
abstract = "Background/Aims: Benign intestinal strictures are common complications in patients with inflammatory bowel disease (IBD). This study aimed to assess the long-term prognosis of endoscopic balloon dilation (EBD) to treat benign strictures in IBD patients. Methods: Patients with IBD who had benign strictures and who underwent EBD in four tertiary referral university hospitals between January 2004 and February 2014 were retrospectively reviewed. Technical success was defined as the ability to pass the scope through the stricture after balloon dilation, and clinical success was defined as improved obstructive symptoms. Results: Forty-two benign strictures were identified in 30 patients (15 males and 15 females). Technical success was achieved in 26 patients (86.7{\%}) at the first EBD attempt and in all 30 patients (100{\%}) at the second EBD attempt. Clinical success was seen in 28 patients (93.3{\%}). The median follow-up duration was 134.8 months (range, 10.2 to 252.0 months), and recurrence occurred in eight patients (26.7{\%}), who required repeat EBD. The median duration to relapse was 1.7 months (range, 0.2 to 6.3 months). During repeat EBD, perforation occurred in two cases (6.7{\%}), which were both clipped successfully. Finally, only one patient (3.3{\%}) underwent surgery for the relief of recurrent obstructive symptoms during the follow-up period. Conclusions: The experience of 10 years shows that EBD is safe and effective for the treatment of benign strictures in IBD patients. Importantly, EBD may allow long-term effective palliation of the symptoms associated with benign intestinal strictures in IBD patients.",
author = "{Korean Association for the Study of the Intestinal Diseases (KASID)} and Lee, {Hye Won} and Park, {Soo Jung} and Jeon, {Seong Ran} and Ye, {Byong Duk} and Park, {Jae Jun} and Cheon, {Jae Hee} and Kim, {Tae Il} and Kim, {Won Ho}",
year = "2018",
month = "9",
doi = "10.5009/gnl17396",
language = "English",
volume = "12",
pages = "530--536",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "5",

}

Korean Association for the Study of the Intestinal Diseases (KASID) 2018, 'Long-term outcomes of endoscopic balloon dilation for benign strictures in patients with inflammatory bowel disease', Gut and liver, vol. 12, no. 5, pp. 530-536. https://doi.org/10.5009/gnl17396

Long-term outcomes of endoscopic balloon dilation for benign strictures in patients with inflammatory bowel disease. / Korean Association for the Study of the Intestinal Diseases (KASID).

In: Gut and liver, Vol. 12, No. 5, 09.2018, p. 530-536.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term outcomes of endoscopic balloon dilation for benign strictures in patients with inflammatory bowel disease

AU - Korean Association for the Study of the Intestinal Diseases (KASID)

AU - Lee, Hye Won

AU - Park, Soo Jung

AU - Jeon, Seong Ran

AU - Ye, Byong Duk

AU - Park, Jae Jun

AU - Cheon, Jae Hee

AU - Kim, Tae Il

AU - Kim, Won Ho

PY - 2018/9

Y1 - 2018/9

N2 - Background/Aims: Benign intestinal strictures are common complications in patients with inflammatory bowel disease (IBD). This study aimed to assess the long-term prognosis of endoscopic balloon dilation (EBD) to treat benign strictures in IBD patients. Methods: Patients with IBD who had benign strictures and who underwent EBD in four tertiary referral university hospitals between January 2004 and February 2014 were retrospectively reviewed. Technical success was defined as the ability to pass the scope through the stricture after balloon dilation, and clinical success was defined as improved obstructive symptoms. Results: Forty-two benign strictures were identified in 30 patients (15 males and 15 females). Technical success was achieved in 26 patients (86.7%) at the first EBD attempt and in all 30 patients (100%) at the second EBD attempt. Clinical success was seen in 28 patients (93.3%). The median follow-up duration was 134.8 months (range, 10.2 to 252.0 months), and recurrence occurred in eight patients (26.7%), who required repeat EBD. The median duration to relapse was 1.7 months (range, 0.2 to 6.3 months). During repeat EBD, perforation occurred in two cases (6.7%), which were both clipped successfully. Finally, only one patient (3.3%) underwent surgery for the relief of recurrent obstructive symptoms during the follow-up period. Conclusions: The experience of 10 years shows that EBD is safe and effective for the treatment of benign strictures in IBD patients. Importantly, EBD may allow long-term effective palliation of the symptoms associated with benign intestinal strictures in IBD patients.

AB - Background/Aims: Benign intestinal strictures are common complications in patients with inflammatory bowel disease (IBD). This study aimed to assess the long-term prognosis of endoscopic balloon dilation (EBD) to treat benign strictures in IBD patients. Methods: Patients with IBD who had benign strictures and who underwent EBD in four tertiary referral university hospitals between January 2004 and February 2014 were retrospectively reviewed. Technical success was defined as the ability to pass the scope through the stricture after balloon dilation, and clinical success was defined as improved obstructive symptoms. Results: Forty-two benign strictures were identified in 30 patients (15 males and 15 females). Technical success was achieved in 26 patients (86.7%) at the first EBD attempt and in all 30 patients (100%) at the second EBD attempt. Clinical success was seen in 28 patients (93.3%). The median follow-up duration was 134.8 months (range, 10.2 to 252.0 months), and recurrence occurred in eight patients (26.7%), who required repeat EBD. The median duration to relapse was 1.7 months (range, 0.2 to 6.3 months). During repeat EBD, perforation occurred in two cases (6.7%), which were both clipped successfully. Finally, only one patient (3.3%) underwent surgery for the relief of recurrent obstructive symptoms during the follow-up period. Conclusions: The experience of 10 years shows that EBD is safe and effective for the treatment of benign strictures in IBD patients. Importantly, EBD may allow long-term effective palliation of the symptoms associated with benign intestinal strictures in IBD patients.

UR - http://www.scopus.com/inward/record.url?scp=85053300746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053300746&partnerID=8YFLogxK

U2 - 10.5009/gnl17396

DO - 10.5009/gnl17396

M3 - Article

C2 - 29730904

AN - SCOPUS:85053300746

VL - 12

SP - 530

EP - 536

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 5

ER -